DioTree is passionately dedicated to developing innovative treatment for high grade serous ovarian cancer (HGSOC), one of the deadliest human cancers with an extremely poor prognosis.

Aug 10, 2023 · Dio Tree has raised $400,000 for its efforts to treat ovarian cancer - something that affects 300,000 women globally each year. “The backdrop of cancer treatment, especially …

Dio-Tree is pioneering a breakthrough solution targeting the DIO3 enzyme, with the goal of developing a revolutionary treatment for ovarian cancer. BIO-Europe is the perfect platform to …

DioTree develops technology for treatment of high grade serous ovarian cancer (HGSOC). A novel technology targeting the DIO3 enzyme to inhibit its function, potentially treating various …

Operator of a pharmaceutical company intended to develop a new mechanism of action and novel small molecule technology for curing ovarian cancer.

Aug 10, 2023 · Dio Tree develops a novel small molecule for the treatment of ovarian cancer. The technology is based on inhibition of the enzyme DIO3, which is a major driver in many types of …

Dio Tree develops a novel, first in class, small molecule for the treatment of ovarian cancer. The new technology is based on inhibition of the enzyme DIO3, which is a major driver in many …

Dio Tree focuses on cancer treatment, specifically targeting high-grade serous ovarian cancer (HGSOC) within the biotechnology and pharmaceutical industry. The company develops novel …

Our mission is to develop novel treatment for high grade serous ovarian cancer (HGSOC) using our innovative small molecule technology targeting the enzyme DIO3🌳🔬 We cordially invite you to...

Apr 13, 2023 · Dio Tree is developing first-in-class small molecule for the treatment of ovarian cancer. The technology is based on inhibition of the enzyme DIO3, a major driver in many …